Cataract/Implant sales rose 6.1 percent to $127.7 million.
Total intraocular lens (IOL) sales rose 13.6 percent to $75.9 million.
Monofocal IOL sales rose 11.5 percent to $63.0 million, reflecting continued strong growth of the Tecnis® IOL franchise.
Refractive IOL sales rose 25.3 percent to $12.9 million, reflecting demand for the companys ReZoom®, Tecnis® Multifocal, VerisyseTM and VeriflexTM IOLs.
Viscoelastic sales declined 4.9 percent to $27.5 million, due primarily to competitive and reimbursement pricing pressure in certain international markets.
Phacoemulsification sales declined 5.4 percent to $20.3 million, due primarily to lower equipment sales ahead of the
planned introduction of the new WhiteStar SignatureTM
phacoemulsification system during the American Society of Cataract and Refractive Surgery annual meeting later this month. Sales were partially offset by 6.4
percent growth in surgical pack sales.